NCT02254837View on ClinicalTrials.gov

Zilver PTX Post-Market Study in Japan

NACompletedINTERVENTIONAL
Enrollment

909

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Peripheral Arterial Disease (PAD)
Interventions
DEVICE

Zilver PTX Drug-Eluting Stent

All Listed Sponsors
lead

Cook Group Incorporated

INDUSTRY

NCT02254837 - Zilver PTX Post-Market Study in Japan | Biotech Hunter | Biotech Hunter